ClinicalTrials.gg
CompletedNCT06978166Updated Nov 6, 2026

Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain

An interventional study of Just-In-Time Adaptive Interventions (JITAIs) and Wysa for Chronic Pain in Chronic Pain and Depression, Anxiety, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 6, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
773
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Chronic Pain by Washington University School of Medicine — 1 open to participants now, 2 under way, none of them phase 3. Chronic Pain · Washington University School of Medicine.

Started
2025
the only one that year
No phase
6 of 10
1 open now
Registered
9th of 10
by date

Among the 10 studies in Chronic Pain by Washington University School of Medicine, this one is the only one that started in 2025, is one of 6 with no phase, and was the 9th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

1 of the 10 studies in Chronic Pain by Washington University School of Medicine is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 45 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Chronic Pain by Washington University School of Medicine, or all of them as a file.
02

Study summary

The purpose of this research study is to refine customized in-app notifications in order to optimize users' experience with a mobile app called Wysa for Chronic Pain. This app is designed to support people who have chronic pain and who also experience symptoms of depression and/or anxiety. This version of the app is not currently available to the public. Eligible participants will be asked to download and use the Wysa for Chronic Pain study app for several weeks, and to use it as they normally would if they were not part of a research study. At the beginning and end of the study period, participants will be asked to complete brief surveys about their mood, pain, physical function, and sleep. Additionally, a few participants will be asked to share their experience with the study app at the end of the research study in a casual interview using a secure audio/video recorded call. Participating in the interview portion is optional.

03

Conditions studied

  • Chronic Pain
  • Depression, Anxiety

Keywords

  • JITAI
  • Digital mental health intervention
  • Older adults
  • Middle-aged adults
  • App
  • Smartphone
  • Chronic pain
  • Depression
  • Anxiety
  • Chatbot
04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 45 years or older
  • At least moderately severe depression and/or anxiety symptoms (Patient Health Questionnaire-9 (PHQ-9) and/or Generalized Anxiety Disorder-7 (GAD-7) score ≥ 10)
  • Chronic pain (i.e., pain on most days or every day in the past three months)

Exclusion criteria

Exclusion Criteria:

  • Frequent active suicidal ideation
  • No access to a mobile device
  • Not living in the United States
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Participant)
Enrollment
773 participants (actual)

Study arms

  • Experimental
    Wysa for Chronic Pain + JITAIs

    Participants assigned to the experimental arm will receive access to the Wysa for Chronic Pain app, and the novel JITAIs that are being tested in this study will be incorporated into the app experience. In an initial 4-week pilot trial, participants in this arm will receive the JITAIs every time the decision rule (i.e., "trigger criteria") is satisfied for that respective JITAI. In subsequent 12-week micro-randomized trials, every time the decision rule for a JITAI is satisfied, participants in this arm will be randomized to receive (versus not receive) the respective JITAI.

    Other: Just-In-Time Adaptive Interventions (JITAIs) · Behavioral: Wysa for Chronic Pain

  • Active comparator
    Wysa for Chronic Pain without JITAIs

    Participants assigned to the control arm will receive access to the Wysa for Chronic Pain app, but the novel JITAIs that are being tested in this study will not be incorporated into the app experience.

    Behavioral: Wysa for Chronic Pain

Interventions

  • OtherJust-In-Time Adaptive Interventions (JITAIs)

    JITAIs are digital interventions that aim to deliver support to a user when the person is most in need and receptive to the intervention. In this study, multiple JITAIs will be tested and refined through completion of an iterative series of randomized trials that are interspersed with qualitative participant interviews. The purpose of each JITAI under investigation is to improve engagement with the Wysa for Chronic Pain app.

  • BehavioralWysa for Chronic Pain

    Wysa for Chronic Pain is an app-based digital mental health intervention that uses a behavioral activation framework and encourages users to work toward pain acceptance. The intervention also includes cognitive behavioral therapy, mindfulness, and sleep tools.

06

What researchers measure

Primary outcomes

  1. Engagement

    The primary outcome for each JITAI is the between-group difference in engagement with Wysa for Chronic Pain during the JITAI's target engagement time interval. Engagement is operationalized as interaction(s) with the digital mental health intervention and is automatically captured throughout the study by the intervention's technical infrastructure. It is not self-reported.

    Time frame: Each JITAI has a different target engagement time interval. e.g., varying from 24 hours to 7 days.

Other outcomes

  1. Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS)

    The PHQ-ADS will be collected as the distal clinical outcome. It is a16-item self-reported measure that is used to assess depression and anxiety symptoms. Scores range from 0 to 48, and higher scores indicate more distress.

    Time frame: Baseline, Week 4, Week 8 (Not in pilot trial), Week 12 (Not in pilot trial)

07

Study locations

1 site
08

References and documents

Publications

  • Cheng AL, Abraham J, Hartz SM, Laber EB, Miller JP. Evaluating and Optimizing Just-in-Time Adaptive Interventions in a Digital Mental Health Intervention (Wysa for Chronic Pain) for Middle-Aged and Older Adults With Chronic Pain: Protocol for a Series of Randomized Trials. JMIR Res Protoc. 2025 Sep 17;14:e77532. doi: 10.2196/77532. PubMed 40961490 ↗

Individual participant data

Plan to share: Yes — De-identified participant-level data will be shared through the NIMH Data Archive (NDA). Access to the dataset will be managed by the NDA.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2025 to primary completion in Oct 2026, 16 months.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 16 months is below that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion Dec 2026 → Oct 2026 and completion Dec 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2025
First posted
May 18, 2025
StartActual
Jun 2, 2025
Primary completionActual
Oct 29, 2026was Dec 2026
CompletionActual
Oct 29, 2026was Dec 2026
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 6, 2026
Primary completion
Dec 2026→Oct 29, 2026 (actual)
Nov 6, 2026
Study completion
Dec 2026→Oct 29, 2026 (actual)
Nov 6, 2026
Enrollment
1000 (estimated)→773 (actual)
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Recruiting→Completed
    Primary completion Dec 2026→Oct 29, 2026 (now actual)
    Study completion Dec 2026→Oct 29, 2026 (now actual)
    Enrollment 1000 (estimated)→773 (actual)
    + 4 other changes: verification date, responsible party, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06978166
Responsible party
Abby Cheng (Associate Professor, Washington University School of Medicine) — Principal investigator
First posted
May 18, 2025
Start date
Jun 2, 2025
Primary completion
Oct 29, 2026
Completion
Oct 29, 2026
Last update
Nov 6, 2026

Study contacts

Abby L. Cheng, MD, MPHS
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion